Bravelle – Urofolitropin 75 IU Injection
UROFOLITROPIN (BRAVELLE) INJECTION – TREATMENT FOR FEMALE INFERTILITY
Urofolitropin or Bravelle 75I.U Injection is used to treat infertility in women. It is prescribed to women who are experiencing ovulation problems or who are undertaking reproductive therapies such as in-vitro fertilization.
Bravelle 75I.U Injection promotes the regular development of an egg in a woman’s ovary (female reproductive organ) and accelerates the release of a healthy, developed egg. This aids in the treatment of female infertility and raises the chances of a successful pregnancy. It is often used in women undergoing fertility therapy or in vitro fertilization (IVF). It is delivered by a doctor or nurse via injection and should not be self-administered. To be effective, you must take the medication exactly as directed.
Bravelle 75I.U Injection is administered through injection under the guidance of a physician. Your doctor or nurse will assist you in determining the best way of self-administration for you. Your doctor will choose the best time to administer the injection, so always follow his or her recommendations.
USES OF UROFOLITROPIN (BRAVELLE) INJECTION
- Female infertility
WORKS OF UROFOLITROPIN (BRAVELLE) INJECTION
Bravelle 75I.U Injection works in females by boosting the release of estrogen, which aids in the growth and development of the egg before to release. It also helps women undergoing assisted reproductive technology procedures grow more follicles (eggs).
Fedelty Health Care is India’s certified Urofolitropin Bulk Pharma Exporter, Cargo Bulk Supplier, and pharmaceutical wholesaler.
SIDE EFFECTS OF UROFOLITROPIN (BRAVELLE) INJECTION
Many adverse effects do not necessitate medical treatment and will go away as your body adjusts to the medication. Consult your doctor if they persist or if you are concerned.
- Abdominal pain
- Pelvic pain
- Abdominal cramp
- Respiratory disorder
- Hot flushes
WARNING & PRECAUTIONS
Bravelle 75I.U Injection typically has no effect on your ability to drive.
Using Bravelle 75I.U Injection during pregnancy is extremely dangerous. Seek the counsel of your doctor, as research on pregnant women and animals has revealed considerable risk to the growing infant.
There is a scarcity of data on the usage of Bravelle 75I.U Injection in patients with kidney dysfunction. Please consult your physician.
Fedelty Health Care is an Urofolitropin bulk pharma exporter (Bravelle Exporter) and a pharmaceutical third-party manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Hospital supply.